DELUCIA DAVID (Chief Financial Officer) reported 1 transaction at KYNTRA BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/10/2026ACC: 0002040705-26-000007
Officer· Chief Financial Officer
Since Mar 2026
-22.00
Net shares
Net seller
$188.10
Total sold
0
Open market trades
0B · 0S
1
Total transactions
22.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−22.00
Price / share
$8.55
Trade value
$188.10
% of position
0.5%
9/6/2026
4.38K→4.36K
Total
Net shares
−22.00
Net value
-$188.10
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/6/2026 | F · Tax Withholding | −22.00 | $8.55 | $188.10 | 0.5% | 4.38K | 4.36K |
| Total | −22.00 | -$188.10 | ||||||
Derivative Transactions0
No derivative transactions reported